We know a lot about the side effects
Some research firms, such as Research and Markets, project the market to grow by a compound annual growth rate (CAGR) of 11.1%, ending 2035 with a valuation of as much as $157.5 billion
Investment Opportunities For investors, the GLP-1 revolution presents multiple entry points beyond the pharmaceutical manufacturers themselves: Next-Generation Formulations : Several biotech companies are developing improved GLP-1 formulationsincluding oral versions, longer-lasting injectables, and combination therapies that address multiple metabolic pathways simultaneously
10.1016/S0140-6736(06)69705-5 35 DuringM
In addition, Dde cleavable linkers, S-S- cleavable linkers, and some other cleavable linkers are also included
Third, it helps the pancreas release the right amount of insulin when blood sugar levels are high